EUVIMEDEUVIMED entdecken
Crossref

A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease

Dong Young Jeong, Chulhong Kim, Dougho Park, Taeyeon Kim, Sungho Ahn, Bum Joon Kim, Sun U Kwon

Translational Stroke Research · 2026

DOI: 10.1007/s12975-026-01472-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Stroke Research, 2026. Verfasst von Dong Young Jeong und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Convergence Science and Technology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Adenosine Triphosphatases. Die Arbeit nennt 20 Literaturangaben. Gefördert von: National Research Foundation of Korea (NRF) grant, MSIT, Basic Science Research Program, NRF, Ministry of Education, Patient-Centered Clinical Research Coordinating Center (PACEN), Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ring finger protein 213 (RNF213) p.R4810K is a genetic susceptibility factor for intracranial arteriopathies. In patients with isolated intracranial arterial steno-occlusive disease (ICAD) without Moyamoya disease (MMD), we developed a phenotype-based triage score to prioritize RNF213 genotyping by enriching the p.R4810K carriage probability. METHODS: We retrospectively analyzed 753 patients with isolated ICAD involving the distal internal carotid artery or middle cerebral artery M1 segment who underwent RNF213 genotyping between January 2010 and November 2022, excluding definite MMD or significant extracranial steno-occlusion. A prespecified score incorporated anterior cerebral artery (ACA) laterality (0/1/2), tandem lesion burden ≥ 3 (0/1), and MMD family history (0/1; weighted ×4). Discrimination, prespecified thresholds (≥ 3 and ≥ 4), and bootstrap-corrected calibration were assessed, with external application in an independent cohort. RESULTS: RNF213 p.R4810K was identified in 289 patients (38.4%). MMD family history showed the strongest association with carriage (adjusted odds ratio [OR] 8.34, 95% confidence interval [CI]: 4.15-16.77, p < 0.001), followed by tandem burden ≥ 3 (adjusted OR 1.76, 95% CI: 1.15-2.69, p = 0.009) and ACA laterality (adjusted OR 1.74, 95% CI: 1.35-2.23, p < 0.001). The score showed moderate discrimination (internal area under the curve [AUC] 0.720; external AUC 0.708). A cutoff ≥ 3 restricted genotyping to 33.5% of patients while capturing 55.7% of carriers, reducing genotyping workload by 66.5%. A cutoff ≥ 4 increased the positive predictive value to 81.7% with 97.6% specificity. CONCLUSIONS: In clinically selected isolated ICAD, a phenotype-based score incorporating lesion distribution and family history may help prioritize RNF213 genotyping and improve genotyping yield in resource-limited settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesAdenosine TriphosphatasesHumansFemalePhenotypeRetrospective StudiesMaleGenotypeMiddle AgedGenetic Predisposition to DiseaseAdultAgedMoyamoya Disease

Stichwörter der Autor:innen

RNF213-related vasculopathyIntracranial arterial diseasePhenotype-based scoring systemSingle nucleotide polymorphism

Substanzen

RNF213 protein, humanUbiquitin-Protein LigasesAdenosine Triphosphatases

Autor:innen und Institutionen

  • School of Convergence Science and Technology, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
  • Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Electrical Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.
  • Department of Mechanical Engineering, Pohang University of Science and Technology, Pohang, Republic of Korea.
  • Medical Device Innovation Center, Pohang University of Science and Technology, Pohang, Republic of Korea.
  • Department of Convergence IT Engineering, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.

Förderung

  • National Research Foundation of Korea (NRF) grant, MSIT
  • Basic Science Research Program, NRF, Ministry of Education
  • Patient-Centered Clinical Research Coordinating Center (PACEN), Ministry of Health & Welfare, Republic of Korea
  • MD-PhD/Medical Scientist Training Program, the Korea Health Industry Development Institute, Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Jeong, D. Y., Kim, C., Park, D., Kim, T., Ahn, S., Kim, B. J., & Kwon, S. U. (2026). A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease. Translational Stroke Research. https://doi.org/10.1007/s12975-026-01472-3

Vancouver

Jeong DY, Kim C, Park D, Kim T, Ahn S, Kim BJ, et al. A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease. Translational Stroke Research. 2026. doi:10.1007/s12975-026-01472-3

BibTeX
@article{Jeong2026,
  author = {Jeong, Dong Young and Kim, Chulhong and Park, Dougho and Kim, Taeyeon and Ahn, Sungho and Kim, Bum Joon and Kwon, Sun U},
  title = {A Phenotype-Based Score to Prioritize RNF213 p.R4810K Genotyping in Isolated Intracranial Steno-Occlusive Disease},
  journal = {Translational Stroke Research},
  year = {2026},
  doi = {10.1007/s12975-026-01472-3}
}
Kostenlos starten →